Outcome | Analysis | Covariates |
---|---|---|
IV antibiotic duration | Primary analysis: Cox regression (superiority) | Trial arm and minimisation factors |
Kaplan Meier plot | Trial arm | |
Log rank test | Trial arm | |
Sub-group analyses: Cox regression (interaction test by model comparison) | Trial arm, minimisation factors, and organ system of infection (lower urinary, lower respiratory, intra-abdominal, bacteraemia, skin, soft tissue) | |
Trial arm, minimisation factors, and whether patients were recruited before or after the pause in recruitment due to COVID-19 | ||
Complier Average Causal Effect (CACE) | Trial arm, minimisation factors, and intervention adherence (“Analysis populations” section) | |
Survivor Average Causal Effect (SACE) | Trial arm, minimisation factors, and mortality before stopping IV antibiotic use (“Sensitivity analyses” section) | |
Safety composite | Primary analysis: Logistic regression (non-inferiority) | Trial arm and minimisation factors |
Sub-group analyses: Logistic regression (interaction test by model comparison) | Trial arm, minimisation factors, and organ system of infection (lower urinary, lower respiratory, intra-abdominal, bacteraemia, skin, soft tissue) | |
Trial arm, minimisation factors, and whether patients were recruited before or after the pause in recruitment due to COVID-19 | ||
Complier Average Causal Effect (CACE) | Trial arm, minimisation factors, and intervention adherence (“Analysis populations” section) |